Literature DB >> 6661605

Effects of ECT on pituitary hormone release: relationship to seizure, clinical variables and outcome.

J F Deakin, I N Ferrier, T J Crow, E C Johnstone, P Lawler.   

Abstract

Prolactin, cortisol, growth hormone and TSH serum levels (before and 15 minutes after treatment) were measured in 62 patients with endogenous depression randomly allocated to real or pseudo-ECT. Prolactin increased significantly more in those receiving real ECT than in those receiving pseudo-ECT, but the size of this effect had diminished by the time of the last (8th) treatment in the trial. Cortisol secretion was also significantly increased following the first treatment by real ECT, but this increase was of significantly smaller size in patients with delusions. Tolerance to the effects of ECT on cortisol secretion was not observed. No effects of ECT on growth hormone or TSH secretion were detected, and no clear evidence was obtained that endocrine responses can be used as a predictor of response to ECT.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6661605     DOI: 10.1192/bjp.143.6.618

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  7 in total

Review 1.  Epilepsy, depression, and growth hormone.

Authors:  Tracy Butler; Patrick Harvey; Lila Cardozo; Yuan-Shan Zhu; Adam Mosa; Emily Tanzi; Fahad Pervez
Journal:  Epilepsy Behav       Date:  2019-02-14       Impact factor: 2.937

2.  Arginine vasopressin, but not corticotropin releasing factor, is a potent stimulator of adrenocorticotropic hormone following electroconvulsive treatment.

Authors:  E Widerlöv; R Ekman; L Jensen; L Borglund; K Nyman
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

Review 3.  Electroconvulsive therapy: Part I. A perspective on the evolution and current practice of ECT.

Authors:  Nancy A Payne; Joan Prudic
Journal:  J Psychiatr Pract       Date:  2009-09       Impact factor: 1.325

4.  The effect of acute and repeated electroconvulsive treatment on plasma beta-endorphin, growth hormone, prolactin and cortisol secretion in depressed patients.

Authors:  A Weizman; I Gil-Ad; D Grupper; S Tyano; Z Laron
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

5.  Repeated electroconvulsive shock produces long-lasting increases in messenger RNA expression of corticotropin-releasing hormone and tyrosine hydroxylase in rat brain. Therapeutic implications.

Authors:  L S Brady; A B Lynn; J R Glowa; D Q Le; M Herkenham
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

6.  Novel candidate genes for ECT response prediction-a pilot study analyzing the DNA methylome of depressed patients receiving electroconvulsive therapy.

Authors:  Nicole Moschny; Tristan Zindler; Kirsten Jahn; Marie Dorda; Colin F Davenport; Lutz Wiehlmann; Hannah B Maier; Franziska Eberle; Stefan Bleich; Alexandra Neyazi; Helge Frieling
Journal:  Clin Epigenetics       Date:  2020-07-29       Impact factor: 6.551

7.  Electroconvulsive therapy and adiposity-related parameters in treatment-resistant depressed patients.

Authors:  Hannah Benedictine Maier; Christoph Pollak; Nicole Moschny; Sermin Toto; Colin Schlatt; Christian K Eberlein; Wolfgang Sperling; Johannes Kornhuber; Kai G Kahl; Stefan Bleich; Alexandra Neyazi; Helge Frieling
Journal:  J Neural Transm (Vienna)       Date:  2022-02-25       Impact factor: 3.850

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.